Sino Biopharmaceutical Limited

HK$5.60As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1177Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR 10.41%
Div yield 2.50%
ROE 14.07%
Biotechnology
Beta (5Y) 0.66
PE TTM 36.54
TSR TTM (18.84%)
Mkt cap HK$99.74B
ROIC 20.62%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.27
12.00%
50.70%
Buy 10|10|10|2|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.06
0.07
0.07
0.07
(3.12%)
(4.08%)
11.14%
8.71%
Revenue¥B
12.59
12.90
13.23
13.43
0.39%
3.26%
5.54%
9.54%
Peers (US$12.72B)
Cap (US$)
PE
19.18B
107.5x
10.23B
—
Capital
TTM
5Y
10Y
Leveragex
2.113
1.146
0.910
EBIT/Intx
0.216
0.506
0.438
Own earn%
102.09
101.02
95.08
Sh yield%
39.33
5.21
6.62
Owners
Insiders/Inst%
11.20
77.38
Short interest%
4.71
SBC / revenue%
4.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
23–30
$1 testx
12.6
Incr. ROIC%
5